Stockscreener 앱 받기
546.09
4.70%
-26.91
시간 외 거래:
546.09
Idexx Laboratories Inc 주식(IDXX)의 최신 뉴스
IDEXX Laboratories Inc. stock rises Monday, still underperforms market - MarketWatch
Is IDEXX Laboratories stock underperforming the Nasdaq? - MSN
IDEXX Laboratories Inc Stock (US45167R1041): valuation metrics in focus for S&P 500 diagnostics name - AD HOC NEWS
IDEXX Laboratories Stock (US45168D1046): Technical signal after 38-day moving average crossover - AD HOC NEWS
IDEXX Laboratories Stock (US45168D1046): Valuation and fundamentals in focus for S&P 500 pet-health - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories stock (US45168D1046): Double-digit jump after strong earnings and Nasdaq 100 outp - AD HOC NEWS
IDEXX Laboratories Stock’s 63% Gross Margin Story: Here’s What the Numbers Say About a $909 Target - TIKR.com
Is It Too Late to Buy IDEXX Laboratories Inc (IDXX) After 3.2% R - GuruFocus
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Is IDEXX Laboratories Stock Underperforming the Nasdaq? - Barchart.com
BARON GROWTH FUND's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
Is Wall Street bullish or bearish on IDEXX Laboratories stock? - MSN
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 26% Upside Potential Amid Robust Revenue Growth - DirectorsTalk Interviews
IDEXX Laboratories touts AI push, inVue Dx momentum at Stifel conference - MSN
Idexx (IDXX) Down 3.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
IDEXX Parasite Test Expansion Links Zoonotic Risk And Valuation Debate - Yahoo Finance
IDEXX (IDXX) EVP Fennell reports RSU vesting and tax share withholding - Stock Titan
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unveiling 25.84% Potential Upside in the Diagnostics Market - DirectorsTalk Interviews
How Investors May Respond To IDEXX (IDXX) Expanding SDMA and Fecal Dx Integration in Diagnostics - Sahm
IDEXX Laboratories Inc stock (US45167R1041): shares steady as investors digest AI strategy and secto - AD HOC NEWS
IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference - Barchart
A Look at IDEXX Laboratories Inc (IDXX) After 3.1% Gain -- GF Va - GuruFocus
IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile - Insider Monkey
IDEXX Laboratories stock (US45168D1046): solid Q1 update keeps animal health growth story in focus - AD HOC NEWS
IDEXX Laboratories Expands Fecal Antigen Testing Platform With Tapeworm Detection - Moomoo
IDEXX Laboratories Inc at Stifel Jaws & Paws Conference Transcript - GuruFocus
IDEXX expands fecal testing to detect taeniid tapeworms By Investing.com - Investing.com Nigeria
Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock? - Barchart.com
IDEXX expands fecal testing to detect taeniid tapeworms - Investing.com
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection - Business Wire
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection – Company Announcement - Financial Times
11 Best Medical Technology Stocks to Buy Right Now - Insider Monkey
IDEXX Laboratories stock (US45168D1046): strong Q1 earnings keep diagnostics specialist in focus - AD HOC NEWS
IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Unveiling a 26.78% Potential Upside in the Diagnostics Arena - DirectorsTalk Interviews
Glenview Trust Co Sells 5,942 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (IDXX) Is Up 5.8% After Embedding SDMA Into Routine Catalyst CLIPs Testing - Sahm
IDEXX Laboratories stock (US45168D1046): institutional selldown and animal health growth story - AD HOC NEWS
Insider sale notice: IDEXX Labs (NASDAQ: IDXX) files Form 144 - Stock Titan
HARVEY INVESTMENT CO LLC's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
3.12%
2.88%
자본화:
|
볼륨(24시간):